Brian Tomlinson
Impact in
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 57
- Hormonal Regulation and Hypertension 22
- Pharmacology 57
- Pharmacogenetics and Drug Metabolism 33
- Pharmacology and Obesity Treatment 20
- Co-authors
- G. Neil ThomasJuliana C.N. ChanPaul ChanJulia CritchleyIris F. F. BenzieMiao HuClive S. CockramOphelia Yin
In The Last Decade
Brian Tomlinson
464 papers receiving 12.4k citations
Hit Papers
Peers
Comparison fields: 5 of 191
- Pharmacology 1.3k
- Endocrinology, Diabetes and Metabolism 2.3k
- Complementary and alternative medicine 987
- Language and Linguistics 1.2k
- Literature and Literary Theory 1.1k
Countries citing papers authored by Brian Tomlinson
This map shows the geographic impact of Brian Tomlinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Tomlinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Tomlinson more than expected).
Fields of papers citing papers by Brian Tomlinson
This network shows the impact of papers produced by Brian Tomlinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Tomlinson. The network helps show where Brian Tomlinson may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Tomlinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 9 | |
| 2 | 2022 | 4 | |
| 3 | 2022 | 8 | |
| 4 | 2022 | 6 | |
| 5 | 2021 | 34 | |
| 6 | 2021 | 7 | |
| 7 | CYP2C19*2 Polymorphism Is Associated with Impaired Oral Clearance of Gliclazide in Healthy Chinese | 2020 | 2 |
| 8 | 2019 | 18 | |
| 9 | 2015 | 6 | |
| 10 | 2013 | 3 | |
| 11 | 2013 | 68 | |
| 12 | 2010 | 15 | |
| 13 | Drug evaluation: tesamorelin, a synthetic human growth hormone releasing factor. | 2006 | 5 |
| 14 | Discover English : language analysis for teachers | 2005 | 2 |
| 15 | 2003 | 211 | |
| 16 | 2000 | 1 | |
| 17 | Talking to Yourself: The Role of the Inner Voice in Language Learning. | 2000 | 12 |
| 18 | Hepatitis related to the Chinese medicine Shou-wu-pian manufactured from Polygonum multiflorum. | 1996 | 80 |
| 19 | Aconitine poisoning due to Chinese herbal medicines: a review. | 1994 | 97 |
| 20 | Reading : upper-intermediate | 1987 | 2 |
About Brian Tomlinson
Brian Tomlinson is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology, Cardiology and Cardiovascular Medicine, Family Practice and Complementary and alternative medicine, having authored 476 papers that have together received 13.4k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (87 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (57 papers), Blood Pressure and Hypertension Studies (36 papers), Pharmacogenetics and Drug Metabolism (33 papers), Drug Transport and Resistance Mechanisms (26 papers), Hormonal Regulation and Hypertension (22 papers), Cancer, Lipids, and Metabolism (21 papers) and Pharmacology and Obesity Treatment (20 papers). The work is most often cited by research in Pharmacology (1.3k citations), Endocrinology, Diabetes and Metabolism (2.3k citations), Complementary and alternative medicine (987 citations), Language and Linguistics (1.2k citations) and Literature and Literary Theory (1.1k citations). Brian Tomlinson has collaborated with scholars based in Hong Kong, China and Taiwan. Frequent co-authors include G. Neil Thomas, Juliana C.N. Chan, Paul Chan, Julia Critchley, Iris F. F. Benzie, Miao Hu, Clive S. Cockram, Ophelia Yin, Hitomi Masuhara and Yim Tong Szeto. Their work appears in journals such as The Journal of Clinical Pharmacology, Atherosclerosis, Expert Opinion on Drug Metabolism & Toxicology, ELT Journal and Expert Opinion on Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.